BOC Sciences to Host Vascular Nano-Delivery Webinar Featuring University of Pennsylvania Expert
TL;DR
BOC Sciences' webinar with Dr. Muzykantov reveals advanced vascular targeting strategies that could provide pharmaceutical companies with competitive advantages in developing more effective drug delivery systems.
The webinar explains how vascular nanomedicine works through cognizant targeting using known binding sites and fortuitous tropism where delivery systems exhibit unexpected homing behaviors to specific vascular targets.
This research advances precision medicine by improving drug delivery efficiency, potentially leading to safer, more effective treatments that enhance patient outcomes and quality of life worldwide.
Discover how fortuitous tropism allows drug delivery systems to unexpectedly home in on vascular targets, revealing nature's surprising pathways for precision medicine breakthroughs.
Found this article helpful?
Share it with your network and spread the knowledge!
BOC Sciences will host a webinar titled "Vascular Nano-Delivery Using Tropism and Targeting" on December 12th, 2025, featuring Dr. Muzykantov from the University of Pennsylvania. The virtual event will address current knowledge in vascular nanomedicine, focusing on optimization strategies for drug delivery systems to reach specific vascular targets. This session represents a significant opportunity for researchers and pharmaceutical professionals to gain insights from one of the field's foundational figures.
Dr. Muzykantov, Founding Co-Director of the PSOM/SEAS Center for Targeted Therapeutics and Translational Nanomedicine (CT3N) at the University of Pennsylvania, brings substantial expertise to the discussion. With over 330 publications and an h-index of 87, his work has been instrumental in advancing vascular targeting therapies. The webinar will explore both cognizant targeting, which relies on known binding sites, and fortuitous tropism, where delivery systems demonstrate unexpected affinity or homing behaviors toward specific vascular regions.
The timing of this event addresses one of pharmaceutical research's most persistent challenges: achieving efficient and precise drug delivery. Current limitations in targeting specific vascular sites often result in suboptimal therapeutic outcomes, increased side effects, and reduced treatment efficacy. By examining advanced delivery strategies, this webinar could provide crucial insights for overcoming biological barriers that have long hindered drug development progress.
As a leading drug discovery CDMO, BOC Sciences offers comprehensive solutions for designing, developing, and enhancing critical delivery systems through their platform at https://www.bocsci.com. Their expertise in advanced delivery carriers, including liposomes, nanoparticles, and microspheres, positions them uniquely to support researchers in navigating complex biological challenges. This collaboration with academic leadership exemplifies the company's commitment to bridging industry and academia to address the latest advancements in targeted therapeutics.
The implications of improved vascular nano-delivery systems extend across multiple therapeutic areas, including cardiovascular diseases, cancer treatments, and inflammatory conditions. More precise targeting could significantly enhance drug bioavailability while reducing systemic side effects, potentially transforming treatment paradigms for numerous conditions. The knowledge shared in this webinar may accelerate the development of next-generation nanomedicines that offer improved safety profiles and therapeutic outcomes.
Registration for the 10:00 AM EST virtual event is currently open through their online registration portal. This educational initiative reflects the growing importance of collaborative knowledge-sharing in advancing pharmaceutical innovation and addressing complex delivery challenges that have broader implications for global healthcare improvement.
Curated from 24-7 Press Release
